ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title |
Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG | Mayo Clinic / David Daniels, MD/PhD | Reach Grants | 2021 | Minnesota |
| Phosphopeptides as shared targets for donor derived T cell therapy of AML | Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD | Innovation Grants | 2021 | New York |
| Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies | Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD | Young Investigator Grants | 2021 | Ohio |
| Role of H3.3-G34R mutation in pediatric high-grade glioma | University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD | Innovation Grants | 2021 | Texas |
| Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders | The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | California |
| Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia | Children’s Hospital of Philadelphia / Jenny Ruiz, MD | Young Investigator Grants | 2021 | Pennsylvania |
| Stapled Peptide PROTAC: A 3-in-1 Treatment for Pediatric Solid Tumors | Dana-Farber Cancer Institute / Loren Walensky, MD/PhD | Reach Grants | 2021 | Massachusetts |
| STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma | University of California San Francisco / Elizabeth Young, MD | Young Investigator Grants | 2021 | California |
| Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma | Columbia University / Darrell Yamashiro, MD/PhD | Innovation Grants | 2021 | New York |
| Targeting EZHIP as a therapeutic strategy for infantile ependymomas | University of Wisconsin - Madison / Peter Lewis, PhD | Innovation Grants | 2021 | Wisconsin |